15 results
8-K
EX-99.1
EDSA
Edesa Biotech Inc
3 Feb 21
Edesa Biotech Receives C$14 million for COVID-19 Study
8:00am
the potential to be an important tool in treating and preventing lung injuries caused by COVID-19. As the government continues to protect and support Canadians
424B5
EDSA
Edesa Biotech Inc
6 Jan 20
Prospectus supplement for primary offering
5:08pm
. If we cannot successfully defend ourselves against claims that our product candidates or products caused injuries, we will incur substantial
10-KT
EX-14.1
EDSA
Edesa Biotech Inc
12 Dec 19
Annual report (with FYE transition)
4:55pm
and health rules and practices and reporting accidents, injuries and unsafe conditions, procedures, or behaviors.
Reporting and Enforcement.
13.1
10-KT
21sihpvdlgj
12 Dec 19
Annual report (with FYE transition)
4:55pm
8-K
EX-10.1
1r3xge0xfy5 qqj15mp5
30 Aug 19
Other Events
4:10pm
DEFM14A
te01gafohyxg8mgr
18 Apr 19
Proxy related to merger
5:08pm
PREM14A
9dcu8aowqfy0s0aa
29 Mar 19
Preliminary proxy related to merger
4:18pm
8-K
EX-2.1
x6huqm uul6
8 Mar 19
Stellar Biotechnologies and Edesa Biotech Sign Share Exchange Agreement
9:16am
DEFA14A
EX-2.1
u4l2uhd60dptg4
8 Mar 19
Additional proxy soliciting materials
9:14am
20FR12G/A
EX-4.18
ien9 80aremw
5 Jul 12
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12G
EX-4
mf0 1r0ggzn
3 Feb 12
Initial registration of securities (foreign private issuers)
12:00am
- Prev
- 1
- Next